Butyryl-tyrosinyl spermine, analogs thereof and methods of prepa

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514415, 514419, 548469, 548503, 552 8, A61K 31655, C07C24716

Patent

active

060018240

ABSTRACT:
The present invention provides a compound having the structure: ##STR1## wherein R.sub.1 is a saturated or unsaturated linear or branched chain alkyl group, or a cholestanyl group; wherein R.sub.2 is a 2-indolyl, 3-indolyl, 4-indolyl, 5-indolyl, 4-hydroxyphenyl, 4-(arylalkyloxy)phenyl, 3,4-dihalophenyl, 4-hydroxy-3,5-dihalophenyl, 4-azidophenyl or 4-halophenyl group; wherein R.sub.3 is H, a linear or branched chain alkyl or alkenyl group, or a phenyl, 2-azidophenyl, 3-azidophenyl, 4-azidophenyl group, or an a alkenylacyl, 3-amino-3-butylpropyl, N-[N-(N-{4-azidobenzoyl}aminopropyl) aminopropyl], cis- or trans-cinnamyl, 2-amino-2-[(4'-azidophenyl)acetyl, (trifluoromethyl)aminoacetyl or D- or L-arginyl group bonded through the .alpha.-carbonyl moiety thereof; R.sub.4 is H, or a linear or branched chain alkyl group; wherein R.sub.5, R.sub.6 and R.sub.7 are independently the same or different and are H, a linear or branched chain alkyl group, an aryl group or an arylalkyl group; wherein n, j and t are each 0 or 1; wherein m, o, p, q, r and s are independently the same or different and are 0, 1 or 2; wherein r+s and m+o are each equal to 2; wherein, if j is 0, p+q is 2; wherein, if j is 1, then p is 1, q is 0 and R.sub.6 is H; and wherein * denotes a D or L configuration. The invention also provides a method of synthesizing the compound. Another aspect of the invention concerns a method of treating a subject afflicted by a disorder associated with binding of an etiological agent to a glutamate receptor.

REFERENCES:
patent: 3888898 (1975-06-01), Koppe et al.
patent: 5218000 (1993-06-01), Usherwood et al.
Anis, N., et al., "Structure-Activity Relationships of Philanthotoxin Analogs and Polyamines on N-Methyl-D-Aspartate and Nicotininc Acetylcholine Receptors," J. Pharmacol. Exp. Ther., 254, 764-772 (1990); U.S.A.
Eldefrawi, A., et al., "Structure and sythesis of a potent glutamate receptor antagonist in wasp venom," Proc. Natl. Acad. Sci. USA, 85, 4910-4913, 1988.
Goodnow, R., et al., "Sythesis of Glutamate Receptor Antagonist Philanthotoxin-433 (PhTX-433) and Its Analogs," Tetrahedron, 46, 3267-3286 (1990); Great Britain.
Kalivretenos, A.G., and Nakanishi, K., J. Org. Chem., 58, 6596-6608 (1993); U.S.A.
Kitts, K.S., and Piek, T., "Action of the Polyamine B-Philanthotoxin an Neuromuscular Transmission in Insects," Neuropharmacology, 25, 1089-1093 (1986); Great Britain.
Nakanishi, K., et al., "Philanthotoxin --433 (PhTX-433), a non-competitive glutamate receptor inhibitor," Pure & Appl. Chem., 62, 1223-1230 (1990); Great Britain.
Piek, T., et al., "Neuromuscular Block in Honeybees by the Venom of the Bee Wolf Wasp (Philanthus triangulum F.)," Toxicon, 13, 199-201 (1975); Great Britain.
Van Wilgenburg, H., et al., "Ion Channel Block in Rat Diaphragm by the Venom of the Digger Wasp Philanthus triangulum," Comp. Biochem. Physiol., 79C, 205-211 (1984); Great Britain.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Butyryl-tyrosinyl spermine, analogs thereof and methods of prepa does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Butyryl-tyrosinyl spermine, analogs thereof and methods of prepa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Butyryl-tyrosinyl spermine, analogs thereof and methods of prepa will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-863548

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.